FindMyKOL
Clinical trialNCT01514565UnknownObservational

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

SponsorThomas Jefferson UniversityEnrollment70Breast Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective observational study aimed to validate biomarkers that predict response.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

    A. Kathleen McClendon, PhDAdam Berger, MDAllison Zibelli, MDBarbara Cavanaugh, MDErik Knudsen, PhDFrederick Fellin, MDMatias Valsecchi, MDRebecca Jaslow, MDSunny Lee, MDTiffany Avery, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
31 Dec 2015
Completion
31 Dec 2018
Last update posted
18 Mar 2015
Registered enrollment
70
Registry id
NCT01514565
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.